Ain Holdings Inc. · TSE:9627
Ain — Q3 FY4/25 Earnings Presentation
17 slides from Ain's earnings presentation, Mar 10, 2025
Slide 1: FY4/25 3Q IR Presentation
FY4/25 3Q IR PRESENTATION March 10, 2025
Slide 2: Results Overview
Results Overview © AIN HOLDINGS INC. All Rights Reserved. 1
Slide 3: Consolidated P/L
Consolidated P/L Net sales increased 13.7% YoY and 1.4% against the plan due to growth at stores opened in the previous year and existing stores in both businesses, as well as supported by the consolidation of Francfranc from this fiscal year. Ordinary profit decreased 9.5% YoY and increased 2.6% ag
Slide 4: Dispensing Pharmacy Business (Consolidated)
Dispensing Pharmacy Business (Consolidated) Net sales increased 7.6% YoY and 1.7% against the plan. Because the number of prescriptions increased due to an outbreak of influenza, and average prescription price rose due to an increase in high-cost prescriptions. Segment profit decreased 11.7% YoY and
Slide 5: Retail Business (Consolidated)
Retail Business (Consolidated) Net sales up 89.0% YoY and 1.1% against the plan, supported by the consolidation of Francfranc from this fiscal year, and due to steady growth in the number of customers and average customer spend at existing AINZ & TULPE stores and those opened in the previous fiscal
Slide 6: Consolidated B/S
Consolidated B/S Net cash became ¥ (6,578) million due to funds procured for the acquisition of shares associated with the consolidation of Francfranc through borrowings, but the shareholders’ equity ratio was 47.1%, maintaining a sound financial structure. End-FY4/24 End-FY4/25 3Q (¥ million) (¥ mi
Slide 7: Assets
Assets The balance of total assets increased ¥49,113 million from the end of the fiscal 2024, mainly reflecting increases in goodwill and merchandise due to the consolidation of Francfranc. Francfranc End-FY4/24 3Q End-FY4/24 End-FY4/25 3Q Change (¥ million) , Cash andand decrease deposits in accoun
Slide 8: Liabilities and Net Assets
Liabilities and Net Assets Accounts payable – trade increased ¥12,734 million due to the consolidation of Francfranc. In addition, short-term and long-term borrowings increased ¥27,735 million due to funds procured from financial institutions for the acquisition of shares of the company. (¥ million)
Slide 9: Review
Review © AIN HOLDINGS INC. All Rights Reserved. 8
Slide 10: Consolidated (YoY results)
Consolidated (YoY results) Ordinary profit decreased ¥1.4 billion YoY due to the effect of dispensing fee revisions in dispensing pharmacy business and increase in labor costs, etc. Net sales Ordinary profit ¥296.3 billion ¥336.8 billion +¥40.5billion ¥15.0 billion ¥13.6 billion ¥(1.4) billion +13.7
Slide 11: Consolidated (vs Revised plan)
Consolidated (vs Revised plan) Ordinary profit increased ¥0.4 billion against the plan due to increase in sales in both dispensing pharmacy business and retail business, etc. Net sales Ordinary profit ¥332.2 billion ¥336.8 billion +¥4.6billion ¥13.2 billion ¥13.6 billion +¥0.4 billion +1.4% +2.6% ■D
Slide 12: Number of Pharmacies and Stores: Opening and Closure
Number of Pharmacies and Stores ■ Plan and Results FY4/25 3Q FY4/25 Plan Results Prospect Dispensing pharmacy 57 41 80 Organic 22 21 40 M&A 35 20 40 Opening Retail 172 172 182 AINZ & TULPE 8 8 16 Francfranc 164 164 166 Total 229 213 262 Dispensing Pharmacy 28 28 47 Closure Retail 3 3 3 Total 31 31 5
Slide 13: FY4/25 Plan (Dispensing Pharmacy Business)
FY4/25 Plan (Dispensing Pharmacy Business) The group forecasts net sales increase 6.3% YoY and segment profit decrease 8.3% YoY because of the average prescription price rose due to an increase in high-cost prescription. FY4/23 FY4/24 FY4/25 YoY YoY （¥ million） results results plan change change(%)
Slide 14: FY4/25 Plan (Retail Business)
FY4/25 Plan (Retail Business) The group forecasts net sales increase 97.0% YoY and segment profit increase 52.5% YoY due to the sales of AINZ & TULPE remained firm, in addition to the consolidation of Francfranc. FY4/23 FY4/24 FY4/25 YoY YoY （¥ million） results results plan change change(%) Net sale
Slide 15: FY4/25 Plan (Consolidated)
FY4/25 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2025 increase 13.4% YoY due to new store openings of dispensing pharmacy business and retail business, as well as supported by the consolidation of Francfranc from this fiscal year. Ordinary profit will dec
Slide 16: AIN HOLDINGS INC. Corporate Planning Division
Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL: +81-3-5333-1812 https://www.ainj.co.jp/corporate/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document has been
Slide 17: AIN GROUP
AIN GROUP